Report Highlights
The market for pain management drugs and devices was valued at $35.4 billion in 2012. Total market valued is expected to reach $41.5 billion in 2017 after increasing at a five-year compound annual growth rate of 3.2%.
Report Includes
- An overview of the global market for pain management drugs, which will address acute vs. chronic pain, treatments, and issues facing healthcare workers.
- Analyses of global market trends, with data from 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- Examination of product categories, use of products, and the competitive landscape.
- Coverage of several significant market trends, including undertreatment issues, professional issues, managed care pain issues, trends in new therapies, product pipelines, generic participation, pain research, drug delivery, and patent expirations.
- Discussion of new regulatory requirements.
- Comprehensive company profiles of major players in the industry.
SCOPE AND FORMAT
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global with a U.S. emphasis. This study will address acute versus chronic pain, treatments, and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts, and competitive analyses.
The report identifies two general segments of pain management:
- Pharmaceuticals.
- Devices.
Within the pharmaceuticals segment several sub-segments are discussed in detail including:
- Narcotic pain management.
- Non-narcotic pain management.
- Antimigraine treatments.
- Anesthetics.
- Other drugs (including fibromyalgia treatments).
The device segment covers several product lines and specifically targets the largest product segments including:
- TENS and neuromuscular stimulators.
- Spinal cord stimulators.
- Other products (including electromagnetic therapies and other treatments).
Each market segment provides detailed information based on product categories, product use, forecasts, and competitive analyses.
Analyst Credentials
Melissa Elder is an experienced healthcare market analyst specializing in medical treatments, equipment and devices. Ms. Elder holds an MBA in Health Care Management and provides consultation to various institutions globally. She has been involved in the healthcare industry since 1996, providing more than 23 years of industry expertise. Ms. Elder has specialized in market research for more than 20 years, focusing on the areas of advanced medical technologies, biological products and animal health. In-depth analysis into more than 100 health-related topics has given Ms. Elder substantial insight into industry dynamics, market influences and future direction of various health markets. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare specialties. She has authored several industry-specific documents and is a well-respected contributor to the market research community. Her writings are published in magazines, newspapers and professional journals. She is also an experienced custom market research writer who has worked with a large variety of clients in many fields who require innumerable variations to research documents.
Related Reports
Pharmacy Automation: Technologies and Global Markets
The global inpatient and outpatient pharmacy automation market was valued at $2.4 billion in 2011 and should reach $2.6 billion in 2012. Total market value is expected to reach nearly $3.9 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8%.
Biosimilars: Global Markets
The global market for biosimilars reached $1.7 billion in 2010 and $2.5 billion in 2011. The market is expected to reach $3.6 billion by 2016, a compound annual growth rate (CAGR) of 7.7%.
Global Markets for Animal Therapeutics and Diagnostics
The total market for animal therapeutics and diagnostics was $30 billion in 2011, up from $25 billion in 2008. By 2016, this market is likely to exceed $42 billion, with a five-year compound annual growth rate (CAGR) of 7.2% from 2011 through 2016.
Global Markets and Technologies for Home Medical Equipment
The global market for home medical equipment (HME) was worth $17.9 billion in 2010, nearly $19 billion in 2011, and is expected to reach $26.2 billion by 2016, a CAGR of 6.7%.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
6G in Healthcare: Global Market
This report provides an analysis of the global market trends for 6G in healthcare. It focuses on the significant driving trends and challenges that affect the global market. The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for 6G in healthcare.
Healthcare Innovation in the GCC
The report provides an analysis of the healthcare landscape in the Gulf Cooperation Council (GCC) countries. The report estimates the Total Addressable Market (TAM) for the GCC healthcare sector from 2024 to 2030, offering country-specific projections. This analysis provides critical insights into the commercial potential and investment opportunities in the region’s rapidly evolving healthcare ecosystem. The countries included in the analysis are Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Oman, and Bahrain.
Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa
This report presents an in-depth analysis of the MENA beauty and personal care market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, opportunities, and market projections for 2030.
Global Markets for Telemedicine Technologies
The global market for telemedicine technologies is projected to grow from $146.9 billion in 2025 to $251.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2030.
Thermo Fisher Scientific Inc.: 360° Company Analysis
This report provides a comprehensive analysis of Thermo Fisher Scientific Inc., covering key details such as key milestones/history, product offerings, technologies, major applications and end-user industries it serves.
Top Trending Reports
Sensors: Technologies and Global Markets
The global market for sensors was valued at $195.1 billion in 2024 and is estimated to increase from $212.5 billion in 2025 to reach $323.3 billion by 2030, at a compound annual growth rate (CAGR) of 8.7% from 2025 through 2030.
Global Cell Line and Membrane Market
The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.
Water and Wastewater Treatment Technologies: Global Markets
The global market for water and wastewater treatment technologies is expected to grow from $350.7 billion in 2025 and is projected to reach $591.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2025 to 2030.
Global Edge AI Market
The global market for edge AI was valued at $8.7 billion in 2024 and is estimated to increase from $11.8 billion in 2025 to reach $56.8 billion by 2030, at a compound annual growth rate (CAGR) of 36.9% from 2025 through 2030.
2024 Medical Devices Research Review
The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.
Report Highlights
- The global market for pain management pharmaceuticals and devices amounted to $19.1 billion in 2008 and is expected to increase to $32.8 billion in 2013. The compound annual growth rate (CAGR) for the 5-year period is projected at 11.5%.
- The pharmaceuticals segment dominated the market at $17.6 billion in 2008. That figure is expected to increase to $30.2 billion in 2013, for a CAGR of 11.5%.
- The devices segment of the market generated $1.48 billion in sales in 2008 and is projected to increase to $2.5 billion in 2013, for a CAGR of 11.4%.
Report Highlights
-
The global pain-management market is worth around $30.9 billion in 2007. It is forecasted to grow at a compound annual growth rate (CAGR) of 5.63% to reach $40.6 billion by the end of the forecast period, 2012.
-
The pharmaceuticals segment of the pain-management market is valued at $29 billion in 2007. It will be worth $38 billion by 2012 at a CAGR of 5.6%.
-
In 2007, market revenue from the medical devices segment is around $1.9 billion. This segment is predicted to grow at a CAGR of 6.5% to reach $2.6 billion by the end of 2012.
Report Highlights
-
This report presents the forecast of the market for pain management through the year 2005. By 2005, it is anticipated that revenues will likely reach $32 billion, growing at an average annual rate of almost 12%.
-
Pain management pharmaceuticals currently hold the largest market revenue position, representing 97% and accounting for $16 billion of the total in 1999. Pharmaceuticals have long been the mainstay of pain management and it is anticipated that they will remain the largest market share throughout the forecast period.
-
Pain management devices account for 3%, representing $418.5 million in 1999. It is anticipated that the device segment will gain market revenue position due to technological advancements and a gradually declining cost increasing demand for current technologies
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More